- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2011
- Public Summary Document (PSD) July 2011 PBAC Meeting - PDF
Trastuzumab – July 2011
Trastuzumab, powder for I.V. infusion, 60 mg and 150 mg, Herceptin® - July 2011
Last updated
11 November 2011